InterVFast——间歇性禁食在心脏康复患者中的有效性与接受度:一项随机对照试验的研究方案
本研究为单中心随机对照试验,评估间歇性禁食(InterVFast)对心脏康复患者减重(主要结局)的有效性,并观察血糖、甘油三酯、胆固醇、高敏C反应蛋白等指标及患者接受度,随访至12个月。研究假设参与InterVFast可改善相关健康结局,作为行为预防策略降低未来心脏事件风险。
要点
- 单中心随机对照试验评估间歇性禁食对心脏康复患者减重的有效性。
- 同时观察血糖、甘油三酯、胆固醇、高敏C反应蛋白及患者接受度。
- 随访包括4周住院康复结束时及后续3个月和12个月。
核心结论
- 研究假设参与InterVFast干预可改善心脏康复患者的相关健康结局,并构成降低未来心脏事件风险、改善整体健康与生活质量的行为预防策略。
研究设计与样本
- 单中心随机对照试验,纳入心脏康复患者,评估InterVFast干预的有效性,主要结局为减重。
- 在住院康复初始和最终检查时收集体重、血样和临床数据;住院期间参与者每日在禁食日记中记录禁食间隔、进食餐次及可行性;对干预组(IG)参与者进行关于感知利弊和接受度的访谈;家庭医生在3个月和12个月(t2和t3)进行标准化随访检查(体重、血样)。
主要发现
- 研究方案未报告结果数据。
关键数值与推荐
- 主要结局为减重;相关结局包括血糖、甘油三酯、胆固醇和高敏C反应蛋白。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research on intermittent fasting has shown that it can improve a variety of health outcomes, including blood sugar control, blood lipid levels and blood pressure. Only few studies document longer periods of fasting, especially in rehabilitation participants. Cardiac inpatient rehabilitation follows a multidisciplinary approach including change of health behaviour to reduce patients' risk of future cardiovascular events. To date, evidence suggests that intermittent fasting can be an effective way to improve health and well-being, but more research is needed to fully understand its long-term effects and factors that promote the implementation. Therefore, the aim of the ongoing InterVFast trial is to investigate the effectiveness of intermittent fasting amongst cardiac rehabilitation patients after 4-week inpatient rehabilitation as well as 3 and 12 months subsequently including patients' perspective. METHODS: This single-centre randomized controlled trial evaluates the effectiveness of the InterVFast intervention in weight loss (primary outcome). We also examine patients' acceptance and the effect on relevant outcomes as blood glucose and triglyceride levels, cholesterol and high-sensitivity C-reactive protein. Weight, blood samples and clinical data are collected as part of the initial and final examination during inpatient rehabilitation. During inpatient rehabilitation, participants daily note fasting intervals and meals eaten as well as practicability in a fasting diary. In addition, interviews about perceived advantages and disadvantages and acceptance are carried out with the participants in the IG. A standardized follow-up examination (weight, blood samples) will be carried out by the family doctor after 3 and 12 months (t2 and t3). DISCUSSION: Compared to other weight-loss intervention studies, our study addresses patients with coronary heart disease and includes patients' acceptance as well as long-term maintenance. It is hypothesized that participation in the InterVfast intervention will improve relevant health outcomes in a sample of cardiac rehabilitation patients and thus constitute a behavioural prevention strategy to reduce the risk of future cardiac events and improve overall health and quality of life. TRIAL REGISTRATION: ClinicalTrials.gov DRKS00023983. Registered on February 17, 2022.
引用
- Pieper C, Kaistha FTH, Schroeer S, et al. InterVFast-effectiveness and acceptance of intermittent fasting in cardiac rehabilitation patients: study protocol of a randomized controlled trial. Trials. 2024. PMID: 38195578. doi:10.1186/s13063-023-07843-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。